Skip to main content
Top

03-12-2023 | NSCLC | Podcast | Article

Episode 7

A deep dive into ADAURA

Cementing the role of adjuvant osimertinib in NSCLC

print
PRINT
insite
SEARCH
Guest:
Dr. Luis Paz-Ares
Host:
Dr. Shreeya Nanda

The ADAURA trial has, as of this year, demonstrated an overall survival benefit with the adjuvant use of osimertinib in people with resectable NSCLC.

We take an in-depth look at the study with Dr. Luis Paz-Ares, who outlines the study findings, discusses the clinical implications, and addresses the pertinent questions raised by the trial.

« Previous episode: OCT for coronary imaging

Episode 8: AI in stroke »

print
PRINT

Related topics